Search by Drug Name or NDC
NDC 55150-0154-10 Acyclovir Sodium 500 mg/10mL Details
Acyclovir Sodium 500 mg/10mL
Acyclovir Sodium is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is ACYCLOVIR SODIUM.
MedlinePlus Drug Summary
Acyclovir injection is used to treat first-time or repeat outbreaks of herpes simplex (a herpes virus infection of the skin and mucus membranes) and to treat herpes zoster (shingles; a rash that can occur in people who have had chickenpox in the past) in people with weak immune systems. It is also used to treat first-time genital herpes outbreaks (a herpes virus infection that causes sores to form around the genitals and rectum from time to time) in people with normal immune systems. Acyclovir injection is used to treat herpes simplex encephalitis (brain infection with swelling caused by the herpes virus) and herpes infections in newborn infants. Acyclovir injection is in a class of antiviral medications called synthetic nucleoside analogues. It works by stopping the spread of the herpes virus in the body. Acyclovir injection will not cure genital herpes and may not stop the spread of genital herpes to other people.
Related Packages: 55150-0154-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acyclovir Injection
Product Information
| NDC | 55150-0154 |
|---|---|
| Product ID | 55150-154_410e306b-e8b9-4ff5-b703-a3005eec272f |
| Associated GPIs | 12405010102030 |
| GCN Sequence Number | 038954 |
| GCN Sequence Number Description | acyclovir sodium VIAL 50 MG/ML INTRAVEN |
| HIC3 | W5A |
| HIC3 Description | ANTIVIRALS, GENERAL |
| GCN | 43396 |
| HICL Sequence Number | 004182 |
| HICL Sequence Number Description | ACYCLOVIR SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Acyclovir Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acyclovir Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/10mL |
| Substance Name | ACYCLOVIR SODIUM |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [ |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203701 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0154-10 (55150015410)
| NDC Package Code | 55150-154-10 |
|---|---|
| Billing NDC | 55150015410 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-154-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2013-10-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |